SenderraRx, an independent specialty pharmacy, announced on Thursday that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology.

The Oncology Distinction recognises Senderra's oncology-focused clinical oversight, medication management, patient education, adherence support, and care coordination for patients navigating complex cancer therapies.

The ACHC reaccreditation adds to Senderra's existing URAC accreditations in Specialty Pharmacy and Mail Service Pharmacy under URAC's version 6.0 standards. Collectively, these accreditations show that Senderra's pharmacy operations, medication distribution, patient management, and service practices have been independently evaluated against current industry standards.